Can remote glucose monitoring tame type 2 diabetes in underserved communities?

NCT ID NCT06939413

First seen Aug 17, 2026 · Last updated Aug 17, 2026

Summary

This study tests whether a diabetes care program using continuous glucose monitors (CGM) and remote patient monitoring can help adults with uncontrolled type 2 diabetes improve their blood sugar levels and reduce diabetes-related distress. Participants will wear a CGM that shows how their glucose responds to food, activity, and medication, while their care team remotely monitors the data and adjusts treatment as needed. The trial will measure changes in A1c, time in range, and diabetes distress over 52 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Continuous glucose monitor (CGM) and remote patient monitoring (RPM)
What this could lead to
If successful, this program could offer a practical, sustainable way to improve blood sugar control and reduce diabetes-related distress in underserved communities.
What could go wrong
This is a small, early-stage study (40 participants) without a control group, so results may not be generalizable. The intervention relies on patient engagement and clinic resources, which may limit its real-world impact.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Community Health Center of Franklin County

    Greenfield, Massachusetts, 01301, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.